Who Owns TENX?

Tenax Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$15.19

+0.89 (+6.19%)

Market Cap

$50.3M

Shares Outstanding

17,197,613

Institutional Holders

23

Total Inst. Value

$9.6M

% of Float Held

QoQ Holder Change

+14

Institutional data as of Q1 2025

New Positions

4

Closed Positions

3

Increased

5

Decreased

3

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BVF INC/IL$2.2M339,549
2VR Adviser, LLC$1.4M208,333
3Vivo Capital, LLC$1.4M208,333
4Integral Health Asset Management, LLCNew$1.1M167,000
5MORGAN STANLEY$792K121,094
6Velan Capital Investment Management LP$546K83,333
7ADAGE CAPITAL PARTNERS GP, L.L.C.$546K83,333
8ADAR1 Capital Management, LLC$450K68,741
9Vestal Point Capital, LP$350K53,439
10GEODE CAPITAL MANAGEMENT, LLC$217K33,341

Biggest Buyers & Sellers This Quarter

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold TENX?

As of Q1 2025, 23 institutional investors report holding TENX (Tenax Therapeutics, Inc.) in their 13F filings.

Which hedge fund owns the most TENX?

The largest institutional holder of TENX is BVF INC/IL with $2.2M in shares.

Are institutions buying or selling TENX?

This quarter, 4 institutions opened new positions in TENX and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.